Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 402-420-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The 'no observed effect level' (NOEL) in this study is 200 mg/kg bw/day. Howerer, clear signs of toxic effects were also not seen in the 1000 mg/kg bw group, which was defined as the 'no observed adverse effect level' (NOAEL).
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Version / remarks:
- OECD 407 (1981)
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- deionised
- Details on oral exposure:
- Method of administration:
gavage - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- Test duration: 28 days
- Frequency of treatment:
- Dosing regime: 7 days/week
- No. of animals per sex per dose:
- Male: 5 animals at 0 mg/kg bw/day
Male: 5 animals at 40 mg/kg bw/day
Male: 5 animals at 200 mg/kg bw/day
Male: 5 animals at 1000 mg/kg bw/day
Female: 5 animals at 0 mg/kg bw/day
Female: 5 animals at 40 mg/kg bw/day
Female: 5 animals at 200 mg/kg bw/day
Female: 5 animals at 1000 mg/kg bw/day - Observations and examinations performed and frequency:
- Behaviour and general health were observed in all animals were observed twice a day during the whole experiment and on week-end once a day. Neurolocial effects, eyes, oral mucosa and effects on the teeth growh were observed weekly. Bodyweight were measured at the start of the experiment and then twice a week.
- Statistics:
- statistical significant differences were analysed by:
Body Weight, hematological parameter, clinical-chemical parameter, Albumin and globulin values, absolute and relative organs weights
PH wert and weight of Urine. - Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- effects observed, treatment-related
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- reduction in the creatine value and alpha-1-globulin values occurred
- Urinalysis findings:
- effects observed, treatment-related
- Description (incidence and severity):
- coloured
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- elevaton of he liver and kidney weights in high dose group
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- Clinical observations:
No mortalities occurred. In the high-dose group, red discoloration of the urine was observed as from the 4th day of testing and red discoloration of the hairless parts of the body as from the 20th day of testing.
Laboratory findings: Haematologically, there were no differences from the controls detected. Clinico-chemically, changes in the form of a significant reduction in the creatine values and the alpha 1-globulin values occurred in particular among the females from the high-dose group.
Effects in organs: In addition, the adrenal weights (absolute and relative) were clearly elevated among the males from the high-dose group as were the relative liver weights of the females from the medium and high-dose groups and the relative kidney weights in the high-dose group. Macroscopically, a slight red discoloration of kidneys was diagnosed among the females as from 40 mg/kg and among the males as from 200 mg/kg. In the high-dose group, all of the animals exhibited clear red discoloration of the kidney, the stomach and the connective tissue and, among the males, of the testes and of the intestine too. Pathohistologically, dose-dependent deposits of the test substance were found in the tubular epithelium of the kidneys of the animals from the medium and high-dose groups, something which was interpreted as reabsorption of dye particles and lysosomal accumulation. All of the other findings were not dose-related and correspond to the spontaneous pathological picture for the age group of the species. - Dose descriptor:
- NOEL
- Effect level:
- 200 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse effects observed
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: dicolouration of inner organs and tissues
- Critical effects observed:
- no
- Conclusions:
- The 'no observed effect level' (NOEL) in this study is 200 mg/kg bw/day. Howerer, clear signs of toxic effects were also not seen in the 1000 mg/kg bw group, hence, the 'no observed adverse effect level' (NOAEL) is considered to be 1000 mg/kg bw/day.
- Executive summary:
Reactive Red 239 was administered overa period of 29 days, SPF-Wistar rats at dose levels of 0, 40, 200 and 1000 mg/kg body weight per day orally by gavage (total 28 applications, 7 days a week).In all experimental groups, the behavior and general health were checked twice daily, on weekends and holidays once daily. Body weight gain and food consumption were determined twice a week; water consumption weekly. Haematological, clinical chemistry and urinalysis tests were performed at the end of the study.
At necropsy, the animals were examined macroscopically for organ changes; the major organs were weighed and relative organ weights were calculated. The most important organs of these animals were collected and histological specimens were prepared and examined for microscopic changes. Body weights, hematology and clinical chemistry parameters, albumin and globulin values, urinalysis (pH, density) and the absolute and relative organ weights were statistically tested for differences compared to the control groups.
The 28-day administration of 1000 mg/kg bw Reactive Red 239 resulted in no compound-related impairment of general health status or body weight gain. Feed and water consumption were also unaffected by the test substance.
The hematological investigations showed no evidence of compound-related toxicity.
The evaluation of the clinical-chemical parameters resulted in lower creatinine values in females of the 1000 mg/kg bw-group. All other changes were within the normal range of the used rat strain and are therefore not related to the administration of the test substance administration. In the animals of the 200 and 1000 mg/kg bw-groups, the urine was brown-yellow to red discolored. Otherwise, the urinalysis was normal.In male animals at 1000 mg/kg bw, the adrenal weights were increased. In females at the 200 and 1000 mg/kg bw, increases in relative liver weights and at 1000 mg/kg bw increases in relative kidney weights were observed.
The macroscopic examinations revealed reddish discoloration of various tissues and organs. The affected organs were the kidneys of the 40 mg/kg bw-group females, 200 mg/kg bw-group males, and 1000 mg/kg bw-group rats, as well as the connective and stomach tissue at 1000 mg/kg bw. In addition, in males the testes and colon were stained red.
Microscopically, dose-dependent increase in deposits of the substance in the proximal tubulesof the kidneys were found in the top two dose groups (200 and 1000 mg/kg bw), which is interpreted to be a sign of reabsorption of the dye resulting in intra-cellular lysosomal storage. No other substance-related changes were observed.
In summary, in this 29-day subacute toxicity test (28 applications in 29 days)the administreation of Reactive Red 239 resulted in a dose-dependent incorporation of the substance in the proximal tubule of the kidneys without causing changes in renal morphology in animals of the 200 and 1000 mg/kg bw groups.Since the clinical chemistry parameters revealed also no evidence of impaired renal function in the 1000 mg/kg bw-group,a toxic effect is unlikely in this dose group.
Consequently, the 'no observed effect level' (NOEL) in this study is 200 mg/kg bw/day. Howerer, clear signs of toxic effects were also not seen in the 1000 mg/kg bw group, which was defined as the 'no observed adverse effect level' (NOAEL).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Reactive Red 239 was administered overa period of 29 days, SPF-Wistar rats at dose levels of 0, 40, 200 and 1000 mg/kg body weight per day orally by gavage (total 28 applications, 7 days a week). In all experimental groups, the behavior and general health were checked twice daily, on weekends and holidays once daily. Body weight gain and food consumption were determined twice a week; water consumption weekly. Haematological, clinical chemistry and urinalysis tests were performed at the end of the study.
At necropsy, the animals were examined macroscopically for organ changes; the major organs were weighed and relative organ weights were calculated. The most important organs of these animals were collected and histological specimens were prepared and examined for microscopic changes. Body weights, hematology and clinical chemistry parameters, albumin and globulin values, urinalysis (pH, density) and the absolute and relative organ weights were statistically tested for differences compared to the control groups.
The 28-day administration of 1000 mg/kg bw Reactive Red 239 resulted in no compound-related impairment of general health status or body weight gain. Feed and water consumption were also unaffected by the test substance.
The hematological investigations showed no evidence of compound-related toxicity.
The evaluation of the clinical-chemical parameters resulted in lower creatinine values in females of the 1000 mg/kg bw-group. All other changes were within the normal range of the used rat strain and are therefore not related to the administration of the test substance administration. In the animals of the 200 and 1000 mg/kg bw-groups, the urine was brown-yellow to red discolored. Otherwise, the urinalysis was normal.
In male animals at 1000 mg/kg bw, the adrenal weights were increased. In females at the 200 and 1000 mg/kg bw, increases in relative liver weights and at 1000 mg/kg bw increases in relative kidney weights were observed.
The macroscopic examinations revealed reddish discoloration of various tissues and organs. The affected organs were the kidneys of the 40 mg/kg bw-group females, 200 mg/kg bw-group males, and 1000 mg/kg bw-group rats, as well as the connective and stomach tissue at 1000 mg/kg bw. In addition, in males the testes and colon were stained red.
Microscopically, dose-dependent increase in deposits of the substance in the proximal tubulesof the kidneys were found in the top two dose groups (200 and 1000 mg/kg bw), which is interpreted to be a sign of reabsorption of the dye resulting in intra-cellular lysosomal storage. No other substance-related changes were observed.
In summary, in this 29-day subacute toxicity test (28 applications in 29 days) the administreation of Reactive Red 239 resulted in a dose-dependent incorporation of the substance in the proximal tubule of the kidneys without causing changes in renal morphology in animals of the 200 and 1000 mg/kg bw groups.Since the clinical chemistry parameters revealed also no evidence of impaired renal function in the 1000 mg/kg bw-group, a toxic effect is unlikely in this dose group.
Consequently, the 'no observed effect level' (NOEL) in this study is 200 mg/kg bw/day. Howerer, signs of toxic effects were also not seen in the 1000 mg/kg bw group, which was defined as the 'no observed adverse effect level' (NOAEL).
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2